Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
14.32
-0.42 (-2.85%)
At close: Mar 6, 2026, 4:00 PM EST
14.17
-0.15 (-1.05%)
After-hours: Mar 6, 2026, 6:58 PM EST
Aurinia Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 283.06 | 235.13 | 175.51 | 134.03 | 45.61 | Upgrade
|
| Revenue Growth (YoY) | 20.38% | 33.97% | 30.95% | 193.89% | -9.01% | Upgrade
|
| Cost of Revenue | 65.17 | 49.03 | 63.79 | 50.65 | 52.23 | Upgrade
|
| Gross Profit | 217.89 | 186.1 | 111.72 | 83.38 | -6.63 | Upgrade
|
| Selling, General & Admin | 101.79 | 172.03 | 195.04 | 196.37 | 173.54 | Upgrade
|
| Other Operating Expenses | -0.17 | 1.55 | 2.48 | -1.52 | 0.57 | Upgrade
|
| Operating Expenses | 101.62 | 173.58 | 197.52 | 194.85 | 174.11 | Upgrade
|
| Operating Income | 116.26 | 12.52 | -85.79 | -111.47 | -180.74 | Upgrade
|
| Interest Expense | -4.33 | -4.84 | -2.78 | - | - | Upgrade
|
| Interest & Investment Income | 13.57 | 16.97 | 17 | 5.12 | 0.53 | Upgrade
|
| Currency Exchange Gain (Loss) | -9.7 | 5.9 | -5.9 | - | - | Upgrade
|
| EBT Excluding Unusual Items | 115.8 | 30.55 | -77.47 | -106.35 | -180.21 | Upgrade
|
| Merger & Restructuring Charges | -1.65 | -23.11 | - | - | - | Upgrade
|
| Pretax Income | 114.16 | 7.45 | -77.47 | -106.35 | -180.21 | Upgrade
|
| Income Tax Expense | -173.05 | 1.7 | 0.55 | 1.83 | 0.76 | Upgrade
|
| Net Income | 287.2 | 5.75 | -78.02 | -108.18 | -180.97 | Upgrade
|
| Net Income to Common | 287.2 | 5.75 | -78.02 | -108.18 | -180.97 | Upgrade
|
| Net Income Growth | 4893.08% | - | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 134 | 143 | 143 | 142 | 129 | Upgrade
|
| Shares Outstanding (Diluted) | 139 | 146 | 143 | 142 | 129 | Upgrade
|
| Shares Change (YoY) | -5.13% | 2.07% | 0.93% | 9.70% | 9.20% | Upgrade
|
| EPS (Basic) | 2.14 | 0.04 | -0.54 | -0.76 | -1.40 | Upgrade
|
| EPS (Diluted) | 2.07 | 0.04 | -0.54 | -0.76 | -1.40 | Upgrade
|
| EPS Growth | 5075.00% | - | - | - | - | Upgrade
|
| Free Cash Flow | 135.41 | 44.11 | -34.18 | -79.82 | -158 | Upgrade
|
| Free Cash Flow Per Share | 0.98 | 0.30 | -0.24 | -0.56 | -1.22 | Upgrade
|
| Gross Margin | 76.98% | 79.15% | 63.66% | 62.21% | -14.53% | Upgrade
|
| Operating Margin | 41.07% | 5.32% | -48.88% | -83.17% | -396.31% | Upgrade
|
| Profit Margin | 101.47% | 2.45% | -44.45% | -80.71% | -396.81% | Upgrade
|
| Free Cash Flow Margin | 47.84% | 18.76% | -19.47% | -59.55% | -346.44% | Upgrade
|
| EBITDA | 135.71 | 31.96 | -74.14 | -108.76 | -177.97 | Upgrade
|
| EBITDA Margin | 47.95% | 13.59% | -42.24% | -81.15% | - | Upgrade
|
| D&A For EBITDA | 19.45 | 19.45 | 11.65 | 2.71 | 2.76 | Upgrade
|
| EBIT | 116.26 | 12.52 | -85.79 | -111.47 | -180.74 | Upgrade
|
| EBIT Margin | 41.07% | 5.32% | -48.88% | -83.17% | - | Upgrade
|
| Effective Tax Rate | - | 22.77% | - | - | - | Upgrade
|
| Revenue as Reported | 283.06 | 235.13 | 175.51 | 134.03 | 45.61 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.